Results of a Safety Pooled Analysis of an Adjuvanted Herpes Zoster Subunit Vaccine in More than 14,500 Participants Aged 50 Years or Older

BACKGROUND: The recombinant herpes zoster (HZ) subunit vaccine (HZ/su) has shown efficacy against HZ in adults ≥50 and ≥70 years of age (YOA), in two pivotal Phase III clinical trials (NCT01165177, NCT01165229). A pooled safety analysis of data from these two efficacy studies was performed, includin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: López-Fauqued, Marta, Campora, Laura, Delannois, Frédérique, El Idrissi, Mohamed, Ledent, Edouard, Diez-Domingo, Javier, McElhaney, Janet, McNeil, Shelly, De Looze, Ferdinandus, Yeo, Wilfred, Silva, Fernanda Tavares Da
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631020/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.1042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados